Fabio Iannotti
Fabio Arturo Iannotti received his Master’s Degree in Biotechnology (Medical curriculum) at the University of Naples "Federico II" in 2006 with the highest score. In 2010, Dr. Iannotti graduated with a Ph.D. in Neuroscience from the same university. During this time, most of his work was focused on exploring the role of voltage-gated Kv7 K+ channels in rare pediatric forms of drug-resistant epilepsy as well as other neurological disorders related to brain ischemia and degeneration. Part of this research was carried out during an internship at the University of California-Davis, USA from 2009 to 2010. In 2011, he started his postdoc at the Institute of Biomolecular Chemistry (ICB)/National Council of Research (CNR), Italy, initiating pioneering studies on the role of endocannabinoids and plant-derived cannabinoids in rare forms of drug-resistant epilepsy as well as skeletal muscle disorders. In 2012 and 2013, he was a visiting researcher at the University of Reading, UK. In 2014, he was promoted to the position of researcher at the ICB and head of the cellular and molecular biology units. In 2023, he became a Senior Researcher at ICB and qualified as a Full Professor of Pharmacology by the Italian Ministry of University and Research (MIUR).